Zydus acquires GI drug ‘Actibile’ — 3 takeaways

Zydus Healthcare, a subsidiary of Cadila Healthcare, acquired gastrointestinal brand ‘Actibile’ from drug firm Albert David, according to The Economic Times.

Advertisement

Here are three takeaways:

1. Actibile falls in the gastroenterology segment and is used for dissolving gall bladder stones.

2. Albert David is the pharmaceutical venture of the Kothari Group, an India-based industrial group.

3. Albert David is involved in manufacturing and marketing branded formulations in India and abroad and also has operations in medical disposables.

More articles on GI & endoscopy:
4 GI physicians in the news — March 25, 2016
Dr. Gregory Scheible 1st in Indiana to implant Orbera intragastric balloon: 4 points
Emails show Olympus hiked up duodenoscope price 28% after CRE outbreak at UCLA: 8 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.